| 1990 |
COX11 encodes a 28 kDa protein tightly associated with the mitochondrial membrane that is required for cytochrome c oxidase assembly but is not a component of purified cytochrome oxidase; loss of COX11 does not affect synthesis or mitochondrial import of cytochrome oxidase subunit polypeptides, suggesting COX11 acts at a terminal assembly stage. |
Yeast genetics (cox11 mutant characterization), immunoblotting with anti-Cox11 antibody, analysis of cytochrome oxidase subunits in wild-type vs. cox11 mutant |
The EMBO journal |
High |
2167832
|
| 1993 |
Analysis of heme constituents in a cox11 mutant revealed absence of heme A and presence of a heme with chromatographic properties of heme O, suggesting COX11 protein may participate in a step of heme A biosynthesis (conversion of heme O to heme A by forming the formyl group), distinct from COX10's farnesyl transferase activity. |
Heme chromatographic analysis of cox11 yeast mutants |
Biochemistry and molecular biology international |
Medium |
8118433
|
| 1998 |
Human COX11 protein is targeted to mitochondria, as demonstrated by in vitro import and protease-protection assays, and shows significant amino acid identity to yeast Cox11 with conservation of functional domains. |
In vitro mitochondrial import assay, protease-protection assay, sequence alignment |
Genomics |
Medium |
9878253
|
| 2002 |
Cox11 is a Cu(I)-binding protein; its soluble C-terminal domain forms a dimer coordinating one Cu(I) per monomer via three thiolate ligands (conserved Cys residues), forming a binuclear Cu(I) cluster. Mutation of any conserved Cys reduces Cu(I) binding and confers respiratory incompetence with reduced cytochrome c oxidase activity. |
In vitro Cu(I) binding assays, X-ray absorption spectroscopy (EXAFS), site-directed mutagenesis of Cys residues, respiratory growth assay, cytochrome c oxidase activity measurement |
The Journal of biological chemistry |
High |
12063264
|
| 2004 |
Cox17 is a specific copper donor to both Sco1 and Cox11 in vitro; purified CuCox17 directly transfers Cu to Cox11 (and Sco1) but not to heterologous proteins (BSA, carbonic anhydrase). A C57Y mutant of Cox17 fails to transfer copper to Sco1 but remains competent for copper transfer to Cox11, demonstrating distinct transfer pathways. Metallation of soluble Cox11 expressed in the yeast cytoplasm requires co-expression of Cox17. |
In vitro copper transfer assay with purified proteins, site-directed mutagenesis of Cox17 (C57Y), yeast cytoplasm expression system with co-expression of soluble Cox11/Sco1 domains |
The Journal of biological chemistry |
High |
15199057
|
| 2004 |
The solution structure of the Cox11 soluble domain (from Sinorhizobium meliloti) reveals a novel beta-immunoglobulin-like fold (beta-barrel); the copper-binding motif with two conserved cysteines is on one face of the barrel. The apoprotein is monomeric with DTT but dimerizes without reductant; Cu(I) binding (confirmed by NMR and EXAFS) induces a dimeric state with two thiolates bridging two Cu(I) ions. |
NMR solution structure determination, EXAFS, biochemical dimerization assays |
The Journal of biological chemistry |
High |
15181013
|
| 2005 |
Cox11 is oriented with its Cu(I)-binding C-terminal domain (~189 residues) exposed in the mitochondrial intermembrane space (IMS) and its N-terminus projecting into the matrix, as shown by protease susceptibility of a C-terminal Myc tag in mitoplasts. The matrix domain of Cox11 lacks a specific function, whereas the Cu(I)-binding/donating function requires the yeast Cox11 IMS sequence; the human Cox11 copper domain cannot functionally replace the yeast sequence. |
Protease protection assay in mitoplasts (topology mapping), functional complementation with Cox11-Rsm22 fusion proteins, SCO1/COX11 chimera analysis |
The Journal of biological chemistry |
High |
15840584
|
| 2005 |
ACDP4 specifically interacts with COX11 (identified by yeast two-hybrid and confirmed in vitro and in vivo); co-expression of ACDP4 and COX11 in HEK293 cells enhances toxicity to copper, manganese, and cobalt compared to either alone, indicating functional coupling in metal ion homeostasis. |
Yeast two-hybrid screen, co-expression in HEK293 cells, metal ion toxicity assay |
Molecular pain |
Low |
15840172
|
| 2006 |
RanBP2 associates with Cox11 in vitro and in vivo via its leucine-rich domain and colocalizes with Cox11; RanBP2's leucine-rich domain exhibits chaperone activity toward intermediate and mature folding species of Cox11, supporting a cytosolic chaperone role during Cox11 biogenesis. Cox11 is a strong inhibitor of hexokinase I (HKI), and RanBP2 suppresses this inhibitory activity of Cox11 over HKI. |
Co-immunoprecipitation (in vivo), in vitro binding assays, chaperone activity assay, HKI activity assay, co-localization studies, RanBP2 haploinsufficient mouse model |
PLoS genetics |
Medium |
17069463
|
| 2015 |
Cox19 (a twin Cx9C IMS protein) interacts dynamically with Cox11 in a redox-regulated manner; Cox11 interaction is critical for stable accumulation of Cox19 in mitochondria. An oxidative modification of a specific cysteine in Cox11 stimulates Cox19 binding via hydrophobic surface residues (conserved Tyr-Leu dipeptides in Cox19), coupling redox status to copper transfer in the IMS during cytochrome c oxidase biogenesis. |
SILAC-based quantitative proteomics, co-immunoprecipitation, mutagenesis of Cox19 Tyr-Leu dipeptides and Cox11 Cys residues, mitochondrial protein stability assays |
Molecular biology of the cell |
High |
25926683
|
| 2021 |
RANBP2 missense mutation (c.1754C>T) causing autosomal dominant acute necrotizing encephalopathy significantly attenuates binding of mutant RANBP2 to COX11 in a GST pull-down assay, linking impaired RANBP2-COX11 interaction to disease pathophysiology. |
GST pull-down assay with recombinant wild-type and mutant RANBP2 proteins |
Neuroscience letters |
Low |
34400285
|
| 2021 |
COX11 has an additional role in cellular redox homeostasis independent of COX assembly: overexpression of Cox11 reduces ROS levels under oxidative stress (paraquat), while COX11 knockout/knockdown reduces ROS levels under normal conditions. Cox11 is functionally redundant with superoxide dismutase 1 (SOD1) under paraquat stress. The conserved Cys219 (AtCOX11) and Cys208 (ScCOX11) are important for this antioxidative function. Overexpression of soluble COX11 variants improves resistance to menadione. |
ROS measurement (yeast and Arabidopsis), genetic epistasis (ΔSccox11ΔScsod1 double mutant), growth assays under oxidative stress, overexpression of soluble Cox11 variants with cysteine mutations |
PloS one |
Medium |
34919594
|
| 2022 |
Biallelic pathogenic variants in human COX11 cause infantile-onset mitochondrial encephalopathy with decreased cellular ATP levels derived from respiration; ATP levels can be rescued by coenzyme Q10 supplementation, revealing an unexpected functional connection between COX11 and CoQ10-dependent energy metabolism. |
Trio genome/exome sequencing, functional studies in patient fibroblasts (ATP measurement), CoQ10 rescue experiment |
Human mutation |
Medium |
36030551
|
| 2021 |
miR-10a-3p directly targets COX11 mRNA (confirmed by dual luciferase reporter assay); increased miR-10a-3p downregulates COX11 expression and activates the NF-κB signaling pathway (decreased IκBα, increased p-IKKα/β and p-p65) in THP-1 macrophages stimulated with Mycoplasma pneumoniae lipid-associated membrane proteins. |
Dual luciferase reporter assay, miR-10a-3p mimic/inhibitor transfection in THP-1 cells, Western blot for NF-κB pathway components |
Journal of thoracic disease |
Low |
34659807
|
| 2023 |
Novel heterozygous COX11 variants in a patient with Leigh-like features show differential effects on yeast growth, respiration, and cellular redox status when modeled in S. cerevisiae; patient fibroblasts show increased sensitivity to oxidative stress. In silico structural analysis suggests impact on human COX11 protein stability and function. |
Yeast complementation assay with humanized COX11 mutations, respiration measurement, ROS assays, patient fibroblast oxidative stress sensitivity, in silico structure-based analysis |
International journal of molecular sciences |
Medium |
38068960
|
| 2025 |
PTBP3-mediated exon 4 skipping in COX11 pre-mRNA generates shorter COX11 transcripts with impaired protein function, reducing mitochondrial copper content and enabling tumor cells to evade cuproptosis. Full-length COX11 is required for proper mitochondrial copper accumulation; antisense oligonucleotides (ASOs) targeting the short COX11 transcripts combined with copper ionophores trigger cuproptosis in gastric cancer models. |
Full-length transcriptome sequencing, gastric cancer cells and patient-derived organoids with PTBP3 manipulation, PDO-based xenograft models, ASO treatment combined with copper ionophores |
Advanced science |
Medium |
40270362
|